Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous N-acetylcysteine and Oseltamivir in Severe Influenza
NCT03900988Phase 3Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2023
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in influenza, sponsored by The Chinese University of Hong Kong. Started May 2023; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03900988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03900988.